| Pharmaceutical Information |
| Drug Name |
Pentamidine |
| Drug ID |
BADD_D01717 |
| Description |
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. |
| Indications and Usage |
For the treatment of pneumonia due to Pneumocystis carinii. |
| Marketing Status |
approved; investigational |
| ATC Code |
P01CX01 |
| DrugBank ID |
DB00738
|
| KEGG ID |
D08333
|
| MeSH ID |
D010419
|
| PubChem ID |
4735
|
| TTD Drug ID |
D05EAM
|
| NDC Product Code |
Not Available |
| UNII |
673LC5J4LQ
|
| Synonyms |
Pentamidine | Pentamidin | Lomidine | NebuPent | Pentamidine Isethionate | Pentam | Pentamidine Mesylate | Diamidine | Pentacarinat |
|
| Chemical Information |
| Molecular Formula |
C19H24N4O2 |
| CAS Registry Number |
100-33-4 |
| SMILES |
C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
